Market Closed -
NSE India S.E.
05:13:48 09/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
159.6
INR
|
-1.51%
|
|
-7.99%
|
-28.92%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,926
|
1,285
|
343.3
|
999.1
|
1,567
|
1,229
|
Enterprise Value (EV)
1 |
2,668
|
2,681
|
1,334
|
2,205
|
3,125
|
2,420
|
P/E ratio
|
18.5
x
|
38
x
|
-3.98
x
|
22.2
x
|
8.89
x
|
4.39
x
|
Yield
|
1.07%
|
0.8%
|
-
|
1.03%
|
0.99%
|
1.26%
|
Capitalization / Revenue
|
0.71
x
|
0.4
x
|
0.15
x
|
0.34
x
|
0.28
x
|
0.19
x
|
EV / Revenue
|
0.99
x
|
0.84
x
|
0.58
x
|
0.76
x
|
0.56
x
|
0.37
x
|
EV / EBITDA
|
12.5
x
|
21.6
x
|
222
x
|
12.9
x
|
8.55
x
|
5.81
x
|
EV / FCF
|
-4.25
x
|
-4.13
x
|
3.1
x
|
-9.04
x
|
-6.99
x
|
11.7
x
|
FCF Yield
|
-23.5%
|
-24.2%
|
32.2%
|
-11.1%
|
-14.3%
|
8.53%
|
Price to Book
|
2.38
x
|
1.57
x
|
0.48
x
|
1.32
x
|
1.71
x
|
1.04
x
|
Nbr of stocks (in thousands)
|
10,326
|
10,326
|
10,326
|
10,326
|
10,326
|
10,326
|
Reference price
2 |
186.5
|
124.4
|
33.25
|
96.75
|
151.8
|
119.0
|
Announcement Date
|
13/07/18
|
09/07/19
|
21/08/20
|
02/07/21
|
30/06/22
|
12/07/23
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,701
|
3,199
|
2,288
|
2,897
|
5,566
|
6,610
|
EBITDA
1 |
212.7
|
124
|
6
|
171
|
365.4
|
416.8
|
EBIT
1 |
187.2
|
95.8
|
-41.6
|
121.7
|
315.2
|
366.2
|
Operating Margin
|
6.93%
|
2.99%
|
-1.82%
|
4.2%
|
5.66%
|
5.54%
|
Earnings before Tax (EBT)
1 |
164.1
|
2.8
|
-128.3
|
66.8
|
233.5
|
379.5
|
Net income
1 |
103.9
|
33.8
|
-86.2
|
45
|
176.3
|
280.2
|
Net margin
|
3.85%
|
1.06%
|
-3.77%
|
1.55%
|
3.17%
|
4.24%
|
EPS
2 |
10.06
|
3.273
|
-8.348
|
4.358
|
17.07
|
27.13
|
Free Cash Flow
1 |
-627.9
|
-649
|
430
|
-243.9
|
-447
|
206.5
|
FCF margin
|
-23.25%
|
-20.29%
|
18.8%
|
-8.42%
|
-8.03%
|
3.12%
|
FCF Conversion (EBITDA)
|
-
|
-
|
7,167.29%
|
-
|
-
|
49.54%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
73.69%
|
Dividend per Share
2 |
2.000
|
1.000
|
-
|
1.000
|
1.500
|
1.500
|
Announcement Date
|
13/07/18
|
09/07/19
|
21/08/20
|
02/07/21
|
30/06/22
|
12/07/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
743
|
1,397
|
990
|
1,206
|
1,558
|
1,190
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.491
x
|
11.27
x
|
165
x
|
7.051
x
|
4.264
x
|
2.856
x
|
Free Cash Flow
1 |
-628
|
-649
|
430
|
-244
|
-447
|
206
|
ROE (net income / shareholders' equity)
|
13.5%
|
4.16%
|
-11.2%
|
6.1%
|
21.1%
|
26.6%
|
ROA (Net income/ Total Assets)
|
6.11%
|
2.3%
|
-1.05%
|
2.89%
|
5.84%
|
6.07%
|
Assets
1 |
1,699
|
1,473
|
8,202
|
1,556
|
3,018
|
4,617
|
Book Value Per Share
2 |
78.50
|
79.00
|
69.50
|
73.30
|
88.80
|
115.0
|
Cash Flow per Share
2 |
3.250
|
2.780
|
0.2500
|
1.700
|
0.7200
|
0.5900
|
Capex
1 |
279
|
280
|
51.3
|
4.4
|
30.3
|
55.5
|
Capex / Sales
|
10.32%
|
8.74%
|
2.24%
|
0.15%
|
0.54%
|
0.84%
|
Announcement Date
|
13/07/18
|
09/07/19
|
21/08/20
|
02/07/21
|
30/06/22
|
12/07/23
|
|
1st Jan change
|
Capi.
|
---|
| -28.92% | 20.04M | | +6.15% | 105B | | -4.19% | 65.16B | | +51.90% | 42.93B | | +17.59% | 39.48B | | +6.89% | 33.27B | | +12.40% | 19.92B | | +16.25% | 17.49B | | +20.35% | 15.43B | | +9.86% | 15.09B |
Other Commodity Chemicals
|